PortfoliosLab logoPortfoliosLab logo
IDNA vs. TRUH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IDNA vs. TRUH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Genomics Immunology and Healthcare ETF (IDNA) and VanEck Healthcare TruSector ETF (TRUH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


IDNA

1D
-1.40%
1M
-7.39%
6M
13.88%
YTD
23.97%
1Y
54.41%
3Y*
12.75%
5Y*
-7.52%
10Y*
ALL TIME*
4.74%

TRUH

1D
-0.52%
1M
-0.28%
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$842.73K$1.44M$1.52M
$23.58K$32.63K$24.16K

IDNA vs. TRUH - Yearly Performance Comparison


Correlation

The correlation between IDNA and TRUH is 0.44, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (All Time)
Calculated using the full available price history since Apr 2, 2026

0.44

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDNA vs. TRUH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

IDNA
IDNA Risk / Return Rank: 8888
Overall Rank
IDNA Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 8888
Sortino Ratio Rank
IDNA Omega Ratio Rank: 8181
Omega Ratio Rank
IDNA Calmar Ratio Rank: 9494
Calmar Ratio Rank
IDNA Martin Ratio Rank: 8888
Martin Ratio Rank

TRUH

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

IDNA vs. TRUH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF (IDNA) and VanEck Healthcare TruSector ETF (TRUH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IDNATRUHDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.34

Calmar ratioReturn relative to maximum drawdown

5.06

Martin ratioReturn relative to average drawdown

13.37

IDNA vs. TRUH - Sharpe Ratio Comparison


Loading charts...

Drawdowns

IDNA vs. TRUH - Drawdown Comparison

The maximum IDNA drawdown since its inception was -68.26%, which is greater than TRUH's maximum drawdown of -4.51%. Use the drawdown chart below to compare losses from any high point for IDNA and TRUH.


Loading charts...

Drawdown Indicators


IDNATRUHDifference

Max Drawdown

Largest peak-to-trough decline

-68.26%

-4.51%

-63.75%

Max Drawdown (1Y)

Largest decline over 1 year

-10.66%

Max Drawdown (3Y)

Largest decline over 3 years

-29.46%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

Current Drawdown

Current decline from peak

-38.88%

-2.75%

-36.13%

Average Drawdown

Average peak-to-trough decline

-36.30%

-1.64%

-34.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.03%

Volatility

IDNA vs. TRUH - Volatility Comparison


Loading charts...

Volatility by Period


IDNATRUHDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.04%

Volatility (6M)

Calculated over the trailing 6-month period

18.24%

Volatility (1Y)

Calculated over the trailing 1-year period

25.03%

17.62%

+7.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.50%

17.62%

+10.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.44%

17.62%

+11.82%

IDNA vs. TRUH - Expense Ratio Comparison

IDNA has a 0.47% expense ratio, which is higher than TRUH's 0.10% expense ratio.


Dividends

IDNA vs. TRUH - Dividend Comparison

IDNA's dividend yield for the trailing twelve months is around 0.87%, more than TRUH's 0.30% yield.


PositionTTM2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF
0.87%1.18%0.98%1.04%0.54%0.70%0.26%0.80%
TRUH
VanEck Healthcare TruSector ETF
0.30%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


IDNA and TRUH have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, TRUH is cheaper at 0.10% per year. The better choice depends on whether you care most about return, fees, risk, or income.

TRUH is cheaper with a 0.10% expense ratio, compared with 0.47% for IDNA.

IDNA has the higher dividend yield at 0.87%, compared with 0.30% for TRUH.

They also come from different issuers: iShares and VanEck. Their fees differ too: 0.47% for IDNA and 0.10% for TRUH.

Portfolio Optimizer

Find the right allocation for IDNA and TRUH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer